Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OCGN · against 322 other Healthcare companies of similar size
Ranked #318 of 323 · scores higher than 2% of peers · safety percentile 1
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)38 peers with a safety percentile of 0–9, including OCGN · Click a bar to see the companies
Mainly because of its debt / equity, beta and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | OCGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 291 reported | Not reported | 0.19× | — | — | 33% |
| BetaLower is better · 308 reported | 2.27 | 0.50 | 3% | 33% | |
| Current ratioHigher is better · 319 reported | 0.80× | 3.08× | 7% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 165M USD | 99 | 50 | |
| 4 | 261M USD | 99 | 97 | |
| 5 | 397M USD | 99 | 37 | |
| 314 | 126M USD | 2 | 32 | |
| 315 | 3.9B SEK (≈$385M) | 2 | 23 | |
| 316 | 289M USD | 1 | 57 | |
| 317 | 474M USD | 1 | 25 | |
| 318 | 253M USD | 1 | 15 | |
| 319 | 133M EUR (≈$147M) | 1 | 36 | |
| 320 | 289M USD | 0 | ||
| 321 | 3.3B CNY (≈$468M) | 0 | 20 | |
| 322 | 307M USD | 0 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score